The compelling evidence that PTX3 is an effective mediator in preventing CMV infection and reactivation as well as subsequent superinfections pinpoints a potential role for PTX3 as a biomarker and therapeutic agent in viral infections and superinfections in the transplantation setting. The gene discussed is PTX3; the disease is viral infectious disease.